TABLETTEN ENTHALTEND CANAGLIFLOZIN

European patent · EP2568971 · Deleted

Register entry

Publication number
EP2568971
Application number
EP11725825
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
May 11, 2011
Published
Mar 20, 2013
Granted
Oct 14, 2020
Deleted
Dec 25, 2021
Reason
Annual fee unpaid
IPC classes
A61K 9/20 (2006.01)
A61K 9/28 (2006.01)
A61K 31/381 (2006.01)
A61P 3/10 (2006.01)
A61P 3/04 (2006.01)
A61P 3/06 (2006.01)
A61P 9/12 (2006.01)
A61P 9/10 (2006.01)
A61K 31/7034 (2006.01)
A61K 31/7042 (2006.01)
A61P 3/08 (2006.01)
A61P 13/12 (2006.01)
A61P 17/02 (2006.01)
A61P 25/00 (2006.01)
A61P 27/02 (2006.01)
Priority
US 333312 P 11.05.2010
PCT application
PCT/JP2011/061354 11.05.2011
PCT publication
WO2011/142478 17.11.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 25, 2021

    Deleted, fee unpaid

    Published in Swissreg on 25.12.2021

  2. Oct 14, 2020

    Granted

    Published in Swissreg on 14.10.2020

Parties

Inventor

SUGIMOTO Masaaki

Osaka-shi, Osaka 541-8505, JP

KINOSHITA Hajime

Osaka-shi, Osaka 541-8505, JP

TOKUDA Takayuki

Osaka-shi, Osaka 541-8505, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.